SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706 Recall
SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706
FDA recall Class II
Ongoing
FDA lists this Class II recall for SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0441-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Sep 17, 2025
- FDA report date
- Nov 12, 2025
- Quantity in commerce
- 2,932 units
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706
Affected model & UDI checker
Search the exact identifiers published for Z-0441-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 969706 | SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706 | Check source notice | Not specified |
FDA code information
REF: 969706. Lot: M404166. Expiration Date: 30Nov2025
Why was this product recalled?
Beckman Coulter has identified that there is an increased probability Synchron Systems Direct LDL Cholesterol (LDLD REF 969706) reagent lot M404166 may generate false high results. The issue was discovered internally and confirmed on August 19, 2025 by Beckman Coulter.
What actions did BECKMAN COULTER, INC. take?
Beckman Coulter notified consignees via letter on about 09/17/2025. Consignees were instructed to discontinue use of SYNCHRON Systems LDLD reagent lot M404166 and contact Customer Technical Support Center for assistance, review the Safety Data Sheet (SDS) and discard according to laboratory s Standard Operating Procedures and/or your local regulations. The SDS is available at www.beckmancoulter.com. Additionally, Beckman Coulter recommends sharing the content of this letter with laboratory and/or medical director regarding the need to perform a retrospective review of the patient results generated from the SYNCHRON Systems LDLD reagent lot M404166 to determine if retesting is necessary.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0441-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology